Viewing Study NCT02129933



Ignite Creation Date: 2024-05-06 @ 2:47 AM
Last Modification Date: 2024-10-26 @ 11:23 AM
Study NCT ID: NCT02129933
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2014-04-24

Brief Title: VEGF-targeted Fluorescence Near-Infrared NIR Endoscopy in PreMalignant Esophageal Lesions
Sponsor: University Medical Center Groningen
Organization: University Medical Center Groningen

Study Overview

Official Title: A Pilot Intervention Study for the Use of VEGF-targeted Fluorescence Near-Infrared NIR Endoscopy in PreMalignant Esophageal Lesions
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VICE
Brief Summary: To improve detection of esophageal premalignant lesions during surveillance endoscopy of patients at risk of developing malignancies for example in Barretts Esophagus BE there is a need for better endoscopic visualization and the ability for targeted biopsies Optical molecular imaging of neoplasia associated biomarkers could form a promising technique to accommodate this need It is known that the biomarker Vascular Endothelial Growth Factor VEGF is overexpressed in dysplastic and neoplastic areas in BE segments versus normal tissue and has proven to be a valid target for molecular imaging The University Medical Center Groningen UMCG developed a fluorescent tracer by labeling the VEGF-targeting humanized monoclonal antibody bevacizumab currently used in anti-cancer therapy with the fluorescent dye IRDye800CW We hypothesize that when bevacizumab-IRDye800CW is administered it accumulates in VEGF expressing high grade dysplasia HGD and esophageal adenocarcinoma EAC enabling early cancer visualization using a newly developed fluorescent NIR fiber-bundle This hypothesis will be tested in this pilot intervention study
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2013-003003-19 EUDRACT_NUMBER None None